CUSIP 89422G107COMTVTXQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
276 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 10.51M | $401.72M | −88.5K | Reduced |
| 2 | Fmr LLC | 9.62M | $367.50M | +6.72M | Added |
| 3 | Blackrock, Inc. | 7.87M | $300.69M | −231.1K | Reduced |
| 4 | Vanguard Group Inc | 6.31M | $241.08M |
| Reduced |
| 5 | State Street Corp | 4.76M | $181.75M | +1.54M | Added |
| 6 | Perceptive Advisors LLC | 4.28M | $163.47M | +483.6K | Added |
| 7 | Nomura Asset Management International Inc. | 3.77M | $144.19M | +3.77M | New Position |
| 8 | Armistice Capital, LLC | 3.76M | $143.82M | −2.96M | Reduced |
| 9 | Adage Capital Partners Gp, L.L.C. | 2.93M | $111.84M | −625.0K | Reduced |
| 10 | Renaissance Technologies LLC | 2.25M | $85.85M | +494.7K | Added |
See every fund holding Travere Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders